Index · Artikel · Russia makes little progress against drugs-Medvedev

Russia makes little progress against drugs-Medvedev

2011-04-18 3
   
Advertisement
résuméIRKUTSK, Russia Russia has failed to make progress in fighting a growing drug epidemic that cuts economic growth by up to three percent every year, President Dmitry Medvedev said on Monday. Russia has the world's third-largest heroin abuse rate and a
Advertisement

Russia makes little progress against drugs-Medvedev


IRKUTSK, Russia Russia has failed to make progress in fighting a growing drug epidemic that cuts economic growth by up to three percent every year, President Dmitry Medvedev said on Monday.

Russia has the world's third-largest heroin abuse rate and accounts for a third of all heroin deaths worldwide, feeding into a demographic disaster that experts say will drain one million people from the workforce every year until 2017.

"In spite of the fact that heightened attention is given to this topic ... changes for better have been very, very few," Medvedev told senior federal and regional officials meeting in the Siberian city of Irkutsk.

The UN's World Health Organization says heroin use has fueled Russia's HIV/AIDS epidemic, one of the fastest growing in the world.

But health workers criticize Moscow for refusing to finance harm reduction programs, like needle exchanges, or legalize the replacement drug methadone.

Medvedev said children as young as 11 were using drugs and it might be necessary to expand drug testing in schools and strengthen other programs.

"There may be reason to think about introducing separate courses in educational programs, especially in disadvantaged areas and those where there is a tendency toward drug use," he said.

The Geneva-based International Aids Society (IAS) has warned that the number of new HIV infections in Russia is likely to grow between 5 and 10 percent a year unless the government takes new measures.

High rates of heavy smoking, alcoholism, pollution, poverty, together with a fall in birth rates in the years after the fall of Communism, underpin U.N. projections that the population will shrink to 116 million by 2050 from 143 million in 2010.

  • Russia makes little progress against drugs-Medvedev

    Russia makes little progress against drugs-Medvedev
    IRKUTSK, Russia Russia has failed to make progress in fighting a growing drug epidemic that cuts economic growth by up to three percent every year, President Dmitry Medvedev said on Monday. Russia has the world's third-largest heroin abuse rate and a
  • Drug approvals at 19-year high belie industry challenges

    Drug approvals at 19-year high belie industry challenges
    LONDON 2015 was a good year for innovation in medicine with the U.S. Food and Drug Administration approving 45 novel drugs, four more than in 2014 and the most since the all-time record of 53 set in 1996. Across the Atlantic, the European Medicines A
  • Democrat Clinton announces plan to battle Alzheimer's

    Democrat Clinton announces plan to battle Alzheimer's
    NEW YORK Democratic presidential candidate Hillary Clinton on Tuesday announced a slate of proposals to battle Alzheimer's disease and seek a cure by 2025, including an increase in funding for research on the disease and related disorders. Clinton ca
    2015-12-22 USACLINTONELECTION
  • Rising drug resistance threatens global progress against TB

    Rising drug resistance threatens global progress against TB
    LONDON The number of people infected with tuberculosis (TB) or dying from it fell in 2012, but global progress on controlling the contagious lung disease is at risk from growing drug resistance. In its annual TB report, the Geneva-based World Health
    2013-10-23 TUBERCULOSISGLOBAL
  • Progress seen in drunk, drugged driving: study

    Progress seen in drunk, drugged driving: study
    CHICAGO More than 30 million Americans admit to drunken driving in the previous 12 months and more than 10 million say they drove while on illicit drugs, according to a survey of driving habits between 2006 and 2009. While alarmingly high, the number
    2010-12-09 DRIVINGDRUNKEN
  • AstraZeneca opens new $224 million drug factory in Russia

    AstraZeneca opens new $224 million drug factory in Russia
    LONDON AstraZeneca opened a new $224 million drug manufacturing and packaging factory in Russia on Tuesday in a move Chief Executive Pascal Soriot said reinforced its long-term commitment to the country. In 2011, the British-based group was one of th
    2015-10-20 RUSSIAAstrazeneca
  • Novartis bone marrow drug improves progression-free survival

    Novartis bone marrow drug improves progression-free survival
    ZURICH An experimental drug from Novartis significantly improved the length of time that patients lived with a type of bone marrow cancer without the disease worsening, according to a late-stage study presented on Monday. The Phase III trial in patie
    2014-06-02 DRUGNOVARTIS
  • Special report: In Russia, a glut of heroin and denial

    Special report: In Russia, a glut of heroin and denial
    TVER, RUSSIA In her one-room flat, as a small shelf of porcelain cats looks on and the smell of mold hangs in the air, Zoya pulls down the left shoulder of her black blouse and readies herself for her next hit. A friend and ex-addict uses a lighter t
    2011-01-25 HEROINRUSSIA
  • Exclusive: German drug firm Stada's failed Russian forays

    Exclusive: German drug firm Stada's failed Russian forays
    LONDON German generic drugmaker Stada, under pressure to curb its reliance on a weakening home market, embarked on two takeover attempts in Russia over the last two years but failed both times following months of exclusive talks. After deciding again
    2012-03-14 RUSSIASTADA
  • World TB cases fall, but drug-resistance a worry : WHO

    World TB cases fall, but drug-resistance a worry : WHO
    CHICAGO New tuberculosis infections dropped 2.2 percent worldwide last year, but with nearly 9 million new infections, the World Health Organization said TB remains a massive problem that could worsen if countries shortchange funding to fight it. In
    2012-10-17 WHO
  • Seattle Genetics and Takeda's cancer drug meets main trial goal

    Seattle Genetics and Takeda's cancer drug meets main trial goal
    n">Seattle Genetics Inc and Takeda Pharmaceutical Co Ltd said their approved cancer drug was successfully used as a consolidation therapy in a late-stage trial for patients with a type of lymphatic cancer. Consolidation therapy kills any cancer ce
  • Parkinson's drugs show promise in resistant TB

    Parkinson's drugs show promise in resistant TB
    CHICAGO Drugs used to treat Parkinson's disease show promise as a new way to stem the rise of drug-resistant forms of tuberculosis, U.S. researchers said on Thursday. They said computer models and lab experiments suggest the drugs tolcapone or Tasmar
    2009-07-03 DRUGS
  • Promising Alzheimer's drug boosts toxic protein

    Promising Alzheimer's drug boosts toxic protein
    CHICAGO Dimebon, Medivation Inc's promising experimental Alzheimer's drug, significantly raised levels of a toxic protein in the brains of mice, yet has been shown to delay thinking problems in human dementia patients, U.S. researchers said on Wednes
    2009-07-15 ALZHEIMERSDIMEBON
  • Novartis lung drug beneficial in late stage study

    Novartis lung drug beneficial in late stage study
    ZURICH Swiss drugmaker Novartis said a respiratory medicine improved lung function and significantly reduced breathlessness in a late stage trial. The once-daily QAB149 drug, which treats chronic obstructive pulmonary disease (COPD), improved a key m
    2009-09-15 NOVARTIS
  • U.N. says millions still lack access to AIDS drugs

    U.N. says millions still lack access to AIDS drugs
    LONDON More than half of the 9.5 million people who need AIDS drugs cannot get them and 33 million people across the world are still infected with the virus that causes it, a United Nations report said on Wednesday. Access to drugs, counseling and te
    2009-09-30 AIDSPROGRESS
  • New WHO guidelines urge phase-out of major HIV drug

    New WHO guidelines urge phase-out of major HIV drug
    GENEVA Countries should phase out the use of stavudine, the most common AIDS drug, because of "long-term, irreversible" side effects in HIV patients including wasting and a nerve disorder, the World Health Organization said on Monday. In sweepin
    2009-11-30 AIDSDRUGS
  • HIV/AIDS drug puzzle cracked

    HIV/AIDS drug puzzle cracked
    LONDON Scientists say they have solved a crucial puzzle about the AIDS virus after 20 years of research and that their findings could lead to better treatments for HIV. British and U.S. researchers said they had grown a crystal that enabled them to s
    2010-02-01 AIDSHIVENZYME
  • U.S. agencies join in bid to speed drug development

    U.S. agencies join in bid to speed drug development
    WASHINGTON With an aim of getting experimental new drugs to people quicker, the U.S. Food and Drug Administration and National Institutes of Health announced a plan on Wednesday to work more closely together. Under the new arrangement, the NIH will b
    2010-02-25 USADRUGSAGENCIES
  • U.S. says "drugged driving" growing threat

    U.S. says "drugged driving" growing threat
    VIENNA Motorists under the influence of drugs are a growing threat on U.S. roads, while the number who drink and drive has fallen thanks to education and law enforcement, a top U.S. drug control official said on Tuesday. The United States is calling
    2010-03-09 USADRUGS
  • China drug list seen boosting Western firms' sales

    China drug list seen boosting Western firms' sales
    LONDON Chinese plans to broaden the list of medicines eligible for a rebate from July will benefit Western drugmakers such as AstraZeneca and Sanofi-Aventis, according to Morgan Stanley analysts. The National Reimbursement Drug List is being updated

TOP

  • Day/
  • Week/
  • Original/
  • Recommand

Updated